Depletion of microglia mitigates cerebrovascular dysfunction in diet-induced obesity mice

Qing Shen1,2, Guo Zhang1,2

  • 1Key Laboratory of Environmental Health, Ministry of Education, Department of Toxicology, School of Public Health, Tongji Medical College, Wuhan, Hubei, China.

Insights

Microglia-driven neuroinflammation contributes to obesity-related cerebrovascular dysfunction. Targeting microglia with PLX3397 improved basilar artery function in diet-induced obesity (DIO) mice.

Area of Science:

  • Neuroscience
  • Vascular Biology
  • Immunology

Background:

  • Obesity is linked to cerebrovascular dysfunction, but mechanisms are unclear.
  • Neuroinflammation is a potential contributor to these vascular issues.

Purpose of the Study:

  • To investigate the role of microglia-mediated neuroinflammation in obesity-related cerebrovascular dysfunction.
  • To assess the therapeutic potential of targeting microglia.

Main Methods:

  • Pharmacological depletion of microglia using PLX3397 in diet-induced obesity (DIO) mice.
  • Assessment of basilar artery structure and function using histology and wire myography.
  • Evaluation of endothelial nitric oxide synthase (eNOS) phosphorylation.
  • Investigation of Interleukin-18 (IL-18) effects on cerebrovascular function.

Main Results:

  • Microglia depletion reduced basilar artery wall thickness and collagen deposition in DIO mice.
  • PLX3397 treatment enhanced eNOS phosphorylation and improved acetylcholine-induced relaxation in basilar arteries.
  • Brain administration of IL-18 impaired cerebrovascular function in normal weight mice.

Conclusions:

  • Neuroinflammation involving microglia is a key factor in obesity-related cerebrovascular dysfunction.
  • Targeting microglia may offer a therapeutic strategy for obesity-associated brain vascular problems.
  • Elevated IL-18 levels may contribute to vascular dysfunction in the brain.

Related Concept Videos